GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Equity-to-Asset

Novonesis AS (Novonesis AS) Equity-to-Asset : 0.49 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Novonesis AS's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2,045 Mil. Novonesis AS's Total Assets for the quarter that ended in Dec. 2023 was $4,154 Mil. Therefore, Novonesis AS's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.49.

The historical rank and industry rank for Novonesis AS's Equity-to-Asset or its related term are showing as below:

NVZMY' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.48   Med: 0.57   Max: 0.65
Current: 0.49

During the past 13 years, the highest Equity to Asset Ratio of Novonesis AS was 0.65. The lowest was 0.48. And the median was 0.57.

NVZMY's Equity-to-Asset is ranked worse than
66.09% of 1572 companies
in the Chemicals industry
Industry Median: 0.59 vs NVZMY: 0.49

Novonesis AS Equity-to-Asset Historical Data

The historical data trend for Novonesis AS's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Equity-to-Asset Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.55 0.48 0.49 0.49

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.46 0.47 0.51 0.49

Competitive Comparison of Novonesis AS's Equity-to-Asset

For the Specialty Chemicals subindustry, Novonesis AS's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's Equity-to-Asset Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Equity-to-Asset falls into.



Novonesis AS Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Novonesis AS's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2045.122/4153.889
=0.49

Novonesis AS's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2045.122/4153.889
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS  (OTCPK:NVZMY) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Novonesis AS Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

Not Just Yogurt Anymore

By PRNewswire 10-26-2023